Ճապոնիա - անգլերեն - すりの適正使用協議会 RAD-AR Council, Japan

asahi kasei pharma corporation - teriparatide acetate - injection

Ճապոնիա - անգլերեն - すりの適正使用協議会 RAD-AR Council, Japan

asahi kasei pharma corporation - teriparatide acetate - injection

Կանադա - անգլերեն - Health Canada

eli lilly canada inc - teriparatide - solution - 250mcg - teriparatide 250mcg - parathyroid agents

Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

dksh singapore pte. ltd. - teriparatide (rdna origin) - injection, solution - 750 mcg/3 ml - teriparatide (rdna origin) 750 mcg/3 ml

Մալայզիա - անգլերեն - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zuellig pharma sdn bhd - teriparatide -

Սինգապուր - անգլերեն - HSA (Health Sciences Authority)

accord healthcare private limited - teriparatide - injection, solution - teriparatide 20 mcg/80μl

Ավստրալիա - անգլերեն - Department of Health (Therapeutic Goods Administration)

eli lilly australia pty ltd - teriparatide -

Ամերիկայի Միացյալ Նահանգներ - անգլերեն - NLM (National Library of Medicine)

novocol pharmaceutical of canada, inc. - teriparatide (unii: 10t9csu89i) (teriparatide - unii:10t9csu89i) - teriparatide injection is indicated. - for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined herein as having a history of osteoporotic fracture or multiple risk factors for fracture) or who have failed or are intolerant to other available osteoporosis therapy. in postmenopausal women with osteoporosis, teriparatide injection reduces the risk of vertebral and nonvertebral fractures. - to increase bone mass in men with primary or hypogonadal osteoporosis at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy. - for the treatment of men and women with osteoporosis associated with sustained systemic glucocorticoid therapy (daily dosage equivalent to 5 mg or greater of prednisone) at high risk for fracture or who have failed or are intolerant to other available osteoporosis therapy. teriparatide injection is contraindicated in patients with hypersensitivity to teriparatide or to any of its excipients. hypersensitivity reactio

Միացյալ Թագավորություն - անգլերեն - MHRA (Medicines & Healthcare Products Regulatory Agency)

eli lilly and company ltd - teriparatide - solution for injection - 250microgram/1ml

Հնդկաստան - անգլերեն - Central Drugs Standard Control Organization

ranbaxy - teriparatide - 750mcg/3ml(teriparatide(r-human) parathyroid hormone (1-34) (250mcg/ml)) - cartridge